v3.26.1
Consolidated Statements of Changes in Equity, Parent - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss), net
Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2024   312,838      
Beginning Balance at Dec. 31, 2024 $ 13,539 $ 11,402 $ 4,066 $ (2,302) $ 373
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 129   118   11
Employee incentive plan (in shares)   547      
Employee incentive plans (49) $ (49)      
Changes in equity of noncontrolling interests (6)       (6)
Common stock dividends (122)   (122)    
Capped call option contracts (150) $ (150)      
Other comprehensive income (loss), net of income taxes (7)     (7)  
Ending Balance (in shares) at Mar. 31, 2025   313,385      
Ending Balance at Mar. 31, 2025 $ 13,334 $ 11,203 4,062 (2,309) 378
Beginning Balance (in shares) at Dec. 31, 2025 312,000 312,355      
Beginning Balance at Dec. 31, 2025 $ 14,853 $ 11,043 5,899 (2,425) 336
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 1,603   1,590   13
Employee incentive plan (in shares)   628      
Employee incentive plans 24 $ 24      
Changes in equity of noncontrolling interests (12)       (12)
Common stock dividends (155)   (155)    
Common stock issued to acquire Calpine (in shares)   49,376      
Common stock issued to acquire Calpine 17,507 $ 17,507      
Other comprehensive income (loss), net of income taxes $ 0     0  
Ending Balance (in shares) at Mar. 31, 2026 362,000 362,359      
Ending Balance at Mar. 31, 2026 $ 33,820 $ 28,574 $ 7,334 $ (2,425) $ 337